INSMED Inc
Global biopharmaceutical company developing therapies for serious and rare diseases.
INSM | US
Overview
Corporate Details
- ISIN(s):
- US4576693075
- LEI:
- Country:
- United States of America
- Address:
- 700 US HIGHWAY 202/206, 8807 BRIDGEWATER
- Website:
- https://insmed.com/
- Sector:
- Manufacturing
Description
Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all INSMED Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for INSMED Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for INSMED Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
